193 related articles for article (PubMed ID: 38465540)
1. Keloids are transcriptionally distinct from normal and hypertrophic scars.
Walter AS; Stocks M; Akova E; Gauglitz G; Hartmann D; Aszodi A; Böcker W; Saller MM; Volkmer E
Eur J Dermatol; 2023 Dec; 33(6):604-611. PubMed ID: 38465540
[TBL] [Abstract][Full Text] [Related]
2. Hypertrophic and keloid scars fail to progress from the CD34
Limandjaja GC; Belien JM; Scheper RJ; Niessen FB; Gibbs S
Br J Dermatol; 2020 Apr; 182(4):974-986. PubMed ID: 31206605
[TBL] [Abstract][Full Text] [Related]
3. Endothelial dysfunction may play a key role in keloid and hypertrophic scar pathogenesis - Keloids and hypertrophic scars may be vascular disorders.
Ogawa R; Akaishi S
Med Hypotheses; 2016 Nov; 96():51-60. PubMed ID: 27959277
[TBL] [Abstract][Full Text] [Related]
4. Characterization of In Vitro Reconstructed Human Normotrophic, Hypertrophic, and Keloid Scar Models.
Limandjaja GC; van den Broek LJ; Breetveld M; Waaijman T; Monstrey S; de Boer EM; Scheper RJ; Niessen FB; Gibbs S
Tissue Eng Part C Methods; 2018 Apr; 24(4):242-253. PubMed ID: 29490604
[TBL] [Abstract][Full Text] [Related]
5. Co-localization of LTBP-2 with FGF-2 in fibrotic human keloid and hypertrophic scar.
Sideek MA; Teia A; Kopecki Z; Cowin AJ; Gibson MA
J Mol Histol; 2016 Feb; 47(1):35-45. PubMed ID: 26644005
[TBL] [Abstract][Full Text] [Related]
6. [Hyperplastic scars and keloids. Part I: basics and prevention].
Baisch A; Riedel F
HNO; 2006 Nov; 54(11):893-904; quiz 905. PubMed ID: 17041777
[TBL] [Abstract][Full Text] [Related]
7. Keloid and Hypertrophic Scars Are the Result of Chronic Inflammation in the Reticular Dermis.
Ogawa R
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28287424
[TBL] [Abstract][Full Text] [Related]
8. The role of altered fatty acid in pathological scars and their dermal fibroblasts.
Yang JX; Li SY; Chen ML; He LR
Chin J Traumatol; 2022 Jul; 25(4):218-223. PubMed ID: 35478090
[TBL] [Abstract][Full Text] [Related]
9. Epithelial-mesenchymal transition in the formation of hypertrophic scars and keloids.
Yuan FL; Sun ZL; Feng Y; Liu SY; Du Y; Yu S; Yang ML; Lv GZ
J Cell Physiol; 2019 Dec; 234(12):21662-21669. PubMed ID: 31106425
[TBL] [Abstract][Full Text] [Related]
10. Altered expression of keratins during abnormal wound healing in human skin.
Prathiba V; Rao KS; Gupta PD
Cytobios; 2001; 104(405):43-51. PubMed ID: 11219730
[TBL] [Abstract][Full Text] [Related]
11. Vascularization pattern in hypertrophic scars and keloids: a stereological analysis.
Amadeu T; Braune A; Mandarim-de-Lacerda C; Porto LC; Desmoulière A; Costa A
Pathol Res Pract; 2003; 199(7):469-73. PubMed ID: 14521263
[TBL] [Abstract][Full Text] [Related]
12. Wnt Signaling Pathway Proteins in Scar, Hypertrophic Scar, and Keloid: Evidence for a Continuum?
Chaudet KM; Goyal A; Veprauskas KR; Nazarian RM
Am J Dermatopathol; 2020 Nov; 42(11):842-847. PubMed ID: 32310858
[TBL] [Abstract][Full Text] [Related]
13. Hypertrophic scars and keloids: Overview of the evidence and practical guide for differentiating between these abnormal scars.
Limandjaja GC; Niessen FB; Scheper RJ; Gibbs S
Exp Dermatol; 2021 Jan; 30(1):146-161. PubMed ID: 32479693
[TBL] [Abstract][Full Text] [Related]
14. Krox20 expression in abnormal scars: An immunohistochemical study.
Bakry OA; Samaka RM; Fayez N; Seleit I
J Cosmet Dermatol; 2022 Oct; 21(10):5116-5126. PubMed ID: 35416391
[TBL] [Abstract][Full Text] [Related]
15. Fibrillin-1 and elastin are differentially expressed in hypertrophic scars and keloids.
Amadeu TP; Braune AS; Porto LC; Desmoulière A; Costa AM
Wound Repair Regen; 2004; 12(2):169-74. PubMed ID: 15086768
[TBL] [Abstract][Full Text] [Related]
16. Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars.
Bock O; Yu H; Zitron S; Bayat A; Ferguson MW; Mrowietz U
Acta Derm Venereol; 2005; 85(3):216-20. PubMed ID: 16040405
[TBL] [Abstract][Full Text] [Related]
17. [The expression of tenascin-C mRNA in keloids and hypertrophic scars].
Han CM; He XJ; Ma Q
Zhonghua Zheng Xing Wai Ke Za Zhi; 2005 Jan; 21(1):40-3. PubMed ID: 15844597
[TBL] [Abstract][Full Text] [Related]
18. Current potential therapeutic strategies targeting the TGF-β/Smad signaling pathway to attenuate keloid and hypertrophic scar formation.
Zhang T; Wang XF; Wang ZC; Lou D; Fang QQ; Hu YY; Zhao WY; Zhang LY; Wu LH; Tan WQ
Biomed Pharmacother; 2020 Sep; 129():110287. PubMed ID: 32540643
[TBL] [Abstract][Full Text] [Related]
19. [Comparative study of collagen in hypertrophic and keloid cicatrix].
Podobed OV; Prozorovskiĭ NN; Kozlov EA; Tsvetkova TA; Vozdvizhenskiĭ SI; Del'vig AA
Vopr Med Khim; 1996; 42(3):240-5. PubMed ID: 9139458
[TBL] [Abstract][Full Text] [Related]
20. Surgical considerations in skin of colour: minimizing pathological scars.
Obi EE
Clin Exp Dermatol; 2022 Aug; 47(8):1429-1437. PubMed ID: 35187688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
